Guven International Guven International
Explore Pages
Güven Healthcare Group

About Obesity and Metabolic Surgery

Obesity is an important global public health problem and it is reported that the prevalence increased by 10-30% in the last decade. In our country, prevalence of obesity is 20.5% for men, 41.0% for women and 30.3% for general population. Most important causes of obesity are overand mis-nutrition and insufficient physical activity, while genetic, environmental, sociocultural and psychological factors interact to cause obesity. Morbid obesity leads to many health problems due to its negative effects on endocrine system, cardiovascular system, respiratory system, gastrointestinal system, skin, genitourinary system, musculoskeletal system and psychosocial condition. The reported rate of obesity-related death is 5% to 13 percent. 

Obesity and Metabolic Surgery Services 
Surgical Treatment for Obesity 
The aim in the treatment of obesity is to reduce obesity-related morbidity and mortality risks by targeting a realistic weight loss, making the individual gain adequate and balanced nutrition habits and increasing the quality of life. Recent advancements and experience in laparoscopic surgery resulted in a significant increase in cases of gastrointestinal surgery that ensures evident and sustainable weight loss in return for low complication risks for the treatment of morbid obesity. The weight loss obtained by surgical procedures leads to total disappearance or regression of co-existing diseases in most obese patients. Large study series show that Laparoscopic Gastric Bypass (Roux-en-Y or Mini Gastric Bypass) and Laparoscopic Vertical Sleeve Gastrectomy are the most efficient treatment modalities to lose weight and cure metabolic disorders in patients with morbid obesity. 

Postoperative Period
Patients are placed on liquid diet in postoperative day 1 under supervision of expert dietician. Mashed foods are allowed following the first fifteen days and patients are switched to solid foods 30 days after the surgery. The expected weight loss in the long-term follow-up is about 70 to 80% of excess weight at the end of the first year. Prof. Gökhan Yağcı, M.D., from Obesity and Metabolic Surgery Department of Güven Health Group, informs you about Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus in this video. Please click to watch the video.

About Obesity and Metabolic Surgery
Doctor
Mobile App

Your Health
In Trusted Hands

The New Güven Health Group Mobile App Is Now Available!

Downloading our app is easy! Choose the link suitable for your operating system and start simplifying your life right away.